Effect of intravenous glucose on intravenous amino acid-induced gallbladder contraction and CCK secretion.
The present study was undertaken to investigate the effect of acute hyperglycemia on the gallbladder contraction induced by intravenous administration of high doses of amino acids (Vamin 18, 250 mg protein/kg/hr). Six healthy volunteers were studied in random order on two occasions during normoglycemia and hyperglycemia with blood glucose levels stabilized at 15 mmol/liter. Gallbladder volumes, measured with ultrasonography, were studied for 60 min before and for 120 min during intravenous infusion of amino acids (IVAA). Administration of IVAA resulted in a significant reduction (P < 0.05) in gallbladder volume from 32 +/- 5 cm3 to 17 +/- 2 cm3 during normoglycemia. During hyperglycemia no significant changes in gallbladder volume were observed in response to IVAA. No significant changes in plasma CCK concentration, the major hormonal stimulus for gallbladder contraction, occurred in response to IVAA. During hyperglycemia, pancreatic polypeptide (PP) secretion, as an indirect measure of vagal cholinergic tone, in response to IVAA was significantly (P < 0.05) reduced compared to normoglycemia. It is concluded that: (1) administration of high doses of IVAA results in significant gallbladder contraction, (2) high doses of IVAA do not stimulate CCK secretion, (3) acute hyperglycemia inhibits IVAA-induced gallbladder contraction, and (4) acute hyperglycemia inhibits basal and stimulated plasma PP secretion, suggesting impaired vagal-cholinergic tone during hyperglycemia.
De Boer
S Y
SY
Department of Gastroenterology, University Hospital Leiden, The Netherlands.
Masclee
A A
AA
Lam
W F
WF
Jansen
J B
JB
Lamers
C B
CB
D000328:Adult; D000596:Amino Acids / Q000008:administration & dosage / Q000494:pharmacology*; D001786:Blood Glucose / Q000502:physiology; D002766:Cholecystokinin / Q000097:blood / Q000378:metabolism*; D005704:Gallbladder / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000503:physiopathology; D005947:Glucose / Q000008:administration & dosage / Q000494:pharmacology*; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D009119:Muscle Contraction / Q000187:drug effects; D010191:Pancreatic Polypeptide / Q000097:blood / Q000378:metabolism; D014463:Ultrasonography
D000596:Amino Acids; D001786:Blood Glucose; D010191:Pancreatic Polypeptide; D002766:Cholecystokinin; D005947:Glucose